Paper Details

  1. Home
  2. Paper Details

[Efficacy and safety of salmeterol (50 microgram) and fluticasone (250 microgram) in a single inhaler device (diskus) in patients with mild to moderate asthma].

Author: , BeehK M, BeierJ, BuhlR, KornmannO, WiewrodtR

Evaluation StudyResearch that systematically evaluates the effectiveness of a particular program or policy. It measures its outcomes and provides important information for future decision-making.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.

Overview

Inhaled corticosteroids and long-acting beta-agonists are first-line agents for the treatment of patients with persisting bronchial asthma. Several lines of evidence have shown, that inhaled corticosteroids and long-acting beta-agonist have multiple synergisms both in vivo and in vitro, leading to improved clinical asthma control.
Paper Details　
Original Abstract of the Article :
Inhaled corticosteroids and long-acting beta-agonists are first-line agents for the treatment of patients with persisting bronchial asthma. Several lines of evidence have shown, that inhaled corticosteroids and long-acting beta-agonist have multiple synergisms both in vivo and in vitro, leading to i...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1055/s-2002-20089

データ提供：米国国立医学図書館（NLM）

Salmeterol and Fluticasone: A Powerful Duo for Asthma Management

Asthma management requires a comprehensive approach, much like a desert explorer preparing for a long journey. This study investigates the efficacy and safety of a combination inhaler containing salmeterol and fluticasone in patients with mild to moderate asthma. The authors highlight the synergistic effects of these medications, both in vitro and in vivo, showing their potential to improve asthma control.

Synergistic Effects in Asthma Management

This study underscores the power of combining salmeterol and fluticasone for asthma management. The authors found that these medications exhibit synergistic effects, both in vitro and in vivo, leading to improved clinical asthma control. The combination inhaler provides a convenient and effective way to manage asthma symptoms.

A Breath of Fresh Air for Asthma Patients

This research offers a promising approach for asthma management, providing a breath of fresh air for those struggling with this condition. The combination inhaler containing salmeterol and fluticasone offers a convenient and effective way to improve asthma control, offering relief and better quality of life for patients.

Dr. Camel's Conclusion

This study demonstrates the synergistic effects of salmeterol and fluticasone, highlighting the benefits of combining these medications for asthma management. The combination inhaler provides a convenient and effective solution for improving asthma control and enhancing patient well-being.

Date :
  1. Date Completed 2002-05-13
  2. Date Revised 2019-12-10
Further Info :

Pubmed ID

11842346

DOI: Digital Object Identifier

10.1055/s-2002-20089

SNS
PICO Info
in preparation
Languages

German

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.